Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Wrist-worn device to encourage use of the weaker arm after a recent stroke

Official title: A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Home Daily Life of Subacute Stroke Survivors

Run by Spaulding Rehabilitation Hospital · NCT06797154 · Data updated 2026-11-12

This trial tests whether a wrist-worn sensor system plus motor and behavioral home coaching helps people 1–6 months after a stroke with moderate arm weakness use their affected arm more than a usual home-exercise program.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment88 (estimated)
SponsorSpaulding Rehabilitation Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedAugust 8, 2025
Main results expectedJune 30, 2026
Study endsAugust 31, 2026
Registry record updatedNovember 28, 2025
Trial IDNCT06797154 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–85 with an anterior circulation ischemic stroke 1–6 months earlier, unilateral upper-extremity hemiparesis with FMA-UE scores 20–45 and SAFE ≥5, intact cognition, and ownership/use of a smartphone are ideal candidates.

Probably not a fit

Patients with severe spasticity (Modified Ashworth ≥3), visual field loss or hemispatial neglect, lack of smartphone access, or very mild/very severe arm impairment outside the trial's FMA range are unlikely to qualify or benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two-arm randomized trial lasting six months that compares the StrokeWear wrist sensor plus a motor and behavioral home intervention with a usual-care home exercise plan. Participants are stratified by baseline motor impairment and time since stroke and are evaluated at baseline, 3 months, and 6 months using measures across the ICF model. The intervention group receives a structured coaching schedule (weekly in month 1, biweekly in months 2–3, and monthly in months 4–6) delivered in-person or remotely by preference, while the control group receives monthly check-ins to update the home exercise program. Upper-extremity motor function and real-world arm use are the primary targets of measurement.

Why it matters

Potential benefit: If successful, the wearable plus coaching could increase everyday use and function of the affected arm and improve independence in daily activities.

How similar studies have gone: Early pilot studies of wearable activity sensors combined with behavioral coaching for post-stroke arm use have shown promising results, but large randomized trials are still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female, 18-85 years of age at the time of enrollment
* Anterior circulation ischemic stroke at least 1 month and no more than 6 months prior to study enrollment;
* Unilateral upper extremity hemiparesis as characterized by initial scores on upper limb subtest of the Fugl-Meyer Assessment (FMA-UE) between 20 and 45;
* Intact cognitive function to understand the study procedures and goal setting (MMSE score above 23 and able to follow 3step command) ;
* Owning a smartphone (iOS or Android) and being familiar and comfortable with and owning a tablet or smartphone
* SAFE score equal or greater than 5

Exclusion Criteria:

* Severe spasticity (defined as a Modified Ashworth scale score of 3 or more) that would prevent safe performance of UE tasks;
* Visual impairments as assessed by the NIH Stroke Scale Visual Field subscale (only subjects with no visual loss will participate in the study); or hemispatial neglect that would impair the subject ability to see the feedback on the app screen (as assessed with the Mesulum cancellation test);
* Individuals with open wounds or recent fracture (less than 3 months) in the upper extremity, fragile skin or active infection;
* Upper-extremity orthopedic injuries or severe pain resulting in movement limitations;
* Diagnosis of other neurological disease; (i.e., Parkinson's disease, multiple sclerosis, ...);
* Severe proprioceptive deficits that impair the ability to process the vibration feedback, as assessed by physical examination during screening;
* Not understanding spoken or written English;
* Contralateral motor deficits as assessed by clinical examination;
* Brainstem and cerebellar stroke.

Where it's running

  • Spaulding Rehabilitation Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Paolo Bonato, PhD — Spaulding Rehabilitation Hospital
  • Study coordinator: Paolo Bonato, PhD
  • Email: pbonato@partners.org
  • Phone: 617-952-6319

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.